{
    "clinical_study": {
        "@rank": "73734", 
        "arm_group": [
            {
                "arm_group_label": "Arm I (enhanced usual care)", 
                "arm_group_type": "Experimental", 
                "description": "Patients undergo enhanced usual care comprising telephonic monitoring, monthly status reports, and an oncology care team for 6 months."
            }, 
            {
                "arm_group_label": "Arm II (enhanced usual care, RCM)", 
                "arm_group_type": "Experimental", 
                "description": "Patients undergo enhanced usual care as in Arm I and participate in an individualized conditioning program delivered by a local physical therapist and coordinated by the RCM for 6 months."
            }, 
            {
                "arm_group_label": "Arm III (enhanced usual, RCM, PCM)", 
                "arm_group_type": "Experimental", 
                "description": "Patients undergo enhanced usual care as in Arm I, participate in an individualized conditioning program coordinated by the RCM as in Arm II, and receive optimized pain management through a PCM for 6 months."
            }
        ], 
        "brief_summary": {
            "textblock": "This randomized clinical trial studies collaborative targeted case management in improving\n      functional status in patients with stage III-IV cancer. Collaborative targeted case\n      management may improve functional status and preserve performance in patients with advanced\n      cancer"
        }, 
        "brief_title": "Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer", 
        "condition": [
            "Cognitive/Functional Effects", 
            "Malignant Neoplasm", 
            "Pain"
        ], 
        "condition_browse": {
            "mesh_term": "Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. Establish the comparative effectiveness of the Collaborative Care to Preserve Performance\n      in Cancer (COPE) trial arms in preserving functional status.\n\n      II. To assess the comparative cost-effectiveness and cost-utility of the COPE interventions.\n\n      OUTLINE: Patients are randomized to 1 of 3 arms.\n\n      ARM I: Patients undergo enhanced usual care comprising telephonic monitoring, monthly status\n      reports, and an oncology care team for 6 months.\n\n      ARM II: Patients undergo enhanced usual care as in Arm I and participate in an\n      individualized conditioning program delivered by a local physical therapist and coordinated\n      by the Rehabilitation Care Manager (RCM) for 6 months.\n\n      ARM III: Patients undergo enhanced usual care as in Arm I, participate in an individualized\n      conditioning program coordinated by the RCM as in Arm II, and receive optimized pain\n      management through a Pain Care Manager (PCM) for 6 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of stage III or stage IV cancer\n\n          -  Life expectancy > 6 months\n\n          -  Ambulatory Post Acute Care (APC) score between 53 and 66\n\n          -  Ability to complete questionnaire(s) by themselves or with assistance\n\n          -  Provide informed written consent\n\n          -  Have working phone to communicate with study team\n\n          -  Fluent in English\n\n          -  Sufficient auditory acuity\n\n          -  Intact cognitive status\n\n        Exclusion Criteria:\n\n          -  Patient is within 2 months of a major surgical procedure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "516", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 8, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01721343", 
            "org_study_id": "MC1193", 
            "secondary_id": "NCI-2012-01603"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Arm I (enhanced usual care)", 
                    "Arm II (enhanced usual care, RCM)", 
                    "Arm III (enhanced usual, RCM, PCM)"
                ], 
                "description": "Undergo telephonic monitoring", 
                "intervention_name": "telephone-based intervention", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Arm II (enhanced usual care, RCM)", 
                    "Arm III (enhanced usual, RCM, PCM)"
                ], 
                "description": "Participate in an individualized conditioning program with an RCM", 
                "intervention_name": "case management", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Arm III (enhanced usual, RCM, PCM)", 
                "description": "Undergo enhanced usual care with an RCM and PCM", 
                "intervention_name": "management of therapy complications", 
                "intervention_type": "Procedure", 
                "other_name": "complications of therapy, management of"
            }, 
            {
                "arm_group_label": [
                    "Arm II (enhanced usual care, RCM)", 
                    "Arm III (enhanced usual, RCM, PCM)"
                ], 
                "description": "Participate in an individualized conditioning program with an RCM", 
                "intervention_name": "physical therapy", 
                "intervention_type": "Procedure", 
                "other_name": "physiotherapy"
            }, 
            {
                "arm_group_label": [
                    "Arm I (enhanced usual care)", 
                    "Arm II (enhanced usual care, RCM)", 
                    "Arm III (enhanced usual, RCM, PCM)"
                ], 
                "description": "Ancillary studies", 
                "intervention_name": "questionnaire administration", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Arm I (enhanced usual care)", 
                    "Arm II (enhanced usual care, RCM)", 
                    "Arm III (enhanced usual, RCM, PCM)"
                ], 
                "description": "Ancillary studies", 
                "intervention_name": "quality-of-life assessment", 
                "intervention_type": "Procedure", 
                "other_name": "quality of life assessment"
            }, 
            {
                "arm_group_label": "Arm I (enhanced usual care)", 
                "description": "Undergo enhanced usual care", 
                "intervention_name": "management of therapy complications", 
                "intervention_type": "Procedure", 
                "other_name": "complications of therapy, management of"
            }, 
            {
                "arm_group_label": "Arm I (enhanced usual care)", 
                "description": "Undergo enhanced usual care", 
                "intervention_name": "assessment of therapy complications", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "Arm II (enhanced usual care, RCM)", 
                    "Arm III (enhanced usual, RCM, PCM)"
                ], 
                "description": "Participate in an individualized conditioning program with an RCM", 
                "intervention_name": "educational intervention", 
                "intervention_type": "Other", 
                "other_name": "intervention, educational"
            }, 
            {
                "arm_group_label": "Arm II (enhanced usual care, RCM)", 
                "description": "Undergo enhanced usual care with an RCM", 
                "intervention_name": "management of therapy complications", 
                "intervention_type": "Procedure", 
                "other_name": "complications of therapy, management of"
            }, 
            {
                "arm_group_label": "Arm II (enhanced usual care, RCM)", 
                "description": "Undergo enhanced usual care with an RCM", 
                "intervention_name": "assessment of therapy complications", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Arm III (enhanced usual, RCM, PCM)", 
                "description": "Undergo enhanced usual care with an RCM and PCM", 
                "intervention_name": "assessment of therapy complications", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 28, 2014", 
        "location": {
            "contact": {
                "last_name": "Mayo Clinic Clinical Trials Office", 
                "phone": "507-538-7623"
            }, 
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55905"
                }, 
                "name": "Mayo Clinic"
            }, 
            "investigator": {
                "last_name": "Andrea L. Cheville, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "MC1193: Collaborative Care to Preserve Performance in Cancer (COPE)", 
        "overall_official": {
            "affiliation": "Mayo Clinic", 
            "last_name": "Andrea Cheville, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "An overall test using a linear contrast across the three arms will be used. If this is significant then tests between individual pairs of arms will follow. A mixed-effects regression model will allow use of multiple APC measurements per subject while allowing for an appropriate within-subject covariance structure. Time will be incorporated as a continuous variable, a polynomial function, or using assessment-specific indicator variables to determine the most parsimonious model that adequately describes the observed patterns.", 
            "measure": "Change in Acute Care CAT (APC) score in cancer patients out to 6 months.", 
            "safety_issue": "No", 
            "time_frame": "Baseline to 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01721343"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Will be analyzed in a similar manner to the primary analysis. Arms II and III, will be aggregated and adherence variables will be used by time interactions to assess whether the rate of change in APC differs based on participants' \"dose\" of TCM-RS components to identify potential mediators of TCM-RS benefits.", 
                "measure": "Pain scores concerning general activity relating to quality of life evaluated by the Godin Leisure-Time Exercise Questionnaire (GLTEQ), Functional Assessment of Cancer Therapy - General (FACT-G) and Cancer Behavior Inventory (CBI) out to 6 months.", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 6 months"
            }, 
            {
                "description": "Will be analyzed in a similar manner to the primary analysis. Arms II and III, will be aggregated and adherence variables will be used by time interactions to assess whether the rate of change in APC differs based on participants' \"dose\" of TCM-RS components to identify potential mediators of TCM-RS benefits.", 
                "measure": "Pain scores concerning enjoyment relating to quality of life evaluated by the Godin Leisure-Time Exercise Questionnaire (GLTEQ), Functional Assessment of Cancer Therapy - General (FACT-G) and Cancer Behavior Inventory (CBI) out to 6 months.", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 6 months"
            }
        ], 
        "source": "Mayo Clinic", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Mayo Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}